Cargando…

Natural killer T cell strategies to combat Epstein–Barr virus infection

Epstein–Barr virus (EBV) infection results in rapid loss of CD1d expression from the surface of infected B cells, thus enabling the virus to evade immune recognition by natural killer T (NKT) cells. Using pharmacologic means to boost CD1d expression, potent NKT cell effector functions can be elicite...

Descripción completa

Detalles Bibliográficos
Autores principales:	Priatel, John J, Chung, Brian K, Tsai, Kevin, Tan, Rusung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Landes Bioscience 2014
Materias:	Author's View
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4063158/ https://www.ncbi.nlm.nih.gov/pubmed/25050206 http://dx.doi.org/10.4161/onci.28329

Ejemplares similares

Immunosurveillance of senescent cancer cells by natural killer cells
por: Iannello, Alexandre, et al.
Publicado: (2014)

ATM activation mediates anticancer immunosurveillance by natural killer and T cells
por: Tang, Melissa LF, et al.
Publicado: (2013)

KLRG1(+) natural killer cells protect against pulmonary metastatic disease by immunosurveillance
por: Renner, Philipp, et al.
Publicado: (2014)

A critical role for natural killer cells in dendritic cell-based anticancer immunotherapy
por: McLellan, Alexander D
Publicado: (2014)

Non-classical MHC Class I molecules regulating natural killer cell function
por: Smyth, Mark J., et al.
Publicado: (2013)

Promoting natural killer cell functions by recombinant immunoligands mimicking an induced self phenotype
por: Kellner, Christian, et al.
Publicado: (2013)

Type II natural killer T cells foster the antitumor activity of CpG-oligodeoxynucleotides
por: Zhao, Jie, et al.
Publicado: (2014)

Epstein-Barr Virus-Positive Natural Killer/T-Cell Lymphoma
por: Cai, Qingqing, et al.
Publicado: (2019)

CD1d Expression and Invariant NKT Cell Responses in Herpesvirus Infections
por: Chung, Brian K., et al.
Publicado: (2015)

Driving Natural Killer cells toward the melanoma tumor battlefield: Autophagy as a valuable therapeutic target
por: Noman, Muhammad Zaeem, et al.
Publicado: (2018)

Invariant natural killer T cells reconstitution and the control of leukemia relapse in pediatric haploidentical hematopoietic stem cell transplantation
por: Casorati, Giulia, et al.
Publicado: (2012)

Invariant NKT cells: Killers and conspirators against cancer
por: Bassiri, Hamid, et al.
Publicado: (2013)

Determinants of response to daratumumab in Epstein-Barr virus-positive natural killer and T-cell lymphoma
por: Mustafa, Nurulhuda, et al.
Publicado: (2021)

Activity of cytokine-induced killer cells against bone and soft tissue sarcoma
por: Sangiolo, Dario, et al.
Publicado: (2014)

Natural killer/T-cell lymphoma with intracranial infiltration and Epstein-Barr virus infection: A case report
por: Li, Nan, et al.
Publicado: (2020)

Cytologic Analysis of Epstein-Barr Virus-Associated T/Natural Killer-Cell Lymphoproliferative Diseases
por: Yachie, Akihiro
Publicado: (2018)

Genomic and transcriptomic landscapes of Epstein-Barr virus in extranodal natural killer T-cell lymphoma
por: Peng, Rou-Jun, et al.
Publicado: (2018)

Combining NK cells and mAb9.2.27 to combat NG2-dependent and anti-inflammatory signals in glioblastoma
por: Kmiecik, Justyna, et al.
Publicado: (2014)

Natural Killer Cells From Children With Type 1 Diabetes Have Defects in NKG2D-Dependent Function and Signaling
por: Qin, Huilian, et al.
Publicado: (2011)

Epstein–Barr virus renders the infected natural killer cell line, NKL resistant to doxorubicin-induced apoptosis
por: Isobe, Y, et al.
Publicado: (2008)

Author Correction: The influence of human genetic variation on Epstein–Barr virus sequence diversity
por: Rüeger, Sina, et al.
Publicado: (2021)

Virus infections in tumors pave the way for tumor-directed DC-vaccines
por: Woller, Norman, et al.
Publicado: (2012)

The latency pattern of Epstein–Barr virus infection and viral IL-10 expression in cutaneous natural killer/T-cell lymphomas
por: Xu, Z-G, et al.
Publicado: (2001)

Diabetes, Epstein-Barr virus and extranodal natural killer/T-cell lymphoma in India: Unravelling the plausible nexus
por: Spadigam, Anita, et al.
Publicado: (2016)

Spontaneous Hepatic Rupture Associated With Epstein-Barr Virus Negative Aggressive Natural Killer Cell Leukemia
por: Can, Nhu Thuy, et al.
Publicado: (2014)

Epstein-Barr Virus-Associated Vesiculopapular Eruption on the Face of a Patient with Natural Killer T Cell Lymphoma
por: Lim, Ji Soo, et al.
Publicado: (2017)

A Case of Hypersensitivity to Mosquito Bite Associated with Epstein-Barr Viral Infection and Natural Killer Cell Lymphocytosis
por: Roh, Eui Jung, et al.
Publicado: (2010)

NKG2A-Expressing Natural Killer Cells Dominate the Response to Autologous Lymphoblastoid Cells Infected with Epstein–Barr Virus
por: Hatton, Olivia, et al.
Publicado: (2016)

Naturally circulating dendritic cells to vaccinate cancer patients
por: Bol, Kalijn F., et al.
Publicado: (2013)

Reactivation of Epstein-Barr Virus Hepatitis in T/Natural Killer (NK) Cells Mimicking Liver T/NK-Cell Lymphoma
por: Kwong, Sara, et al.
Publicado: (2020)

NK cell-released exosomes: Natural nanobullets against tumors
por: Fais, Stefano
Publicado: (2013)

Epstein-Barr virus infection mechanisms
por: Chesnokova, Liudmila S., et al.
Publicado: (2014)

Epstein–Barr Virus Infection in Cancer
por: Mundo, Lucia, et al.
Publicado: (2023)

Escape from senescence: revisiting cancer therapeutic strategies
por: Zampetidis, Christos P., et al.
Publicado: (2022)

Correction for Wood et al., “Enhancer Control of MicroRNA miR-155 Expression in Epstein-Barr Virus-Infected B Cells”
por: Wood, C. David, et al.
Publicado: (2019)

Author Correction: Epidemiological risk factors associated with primary infection by Epstein–Barr virus in HIV-1-positive subjects in the Brazilian Amazon region
por: Pereira, Leonn Mendes Soares, et al.
Publicado: (2022)

Attenuated measles virus used as an oncolytic virus activates myeloid and plasmacytoid dendritic cells
por: Fonteneau, Jean-François, et al.
Publicado: (2013)

Of microspheres and microbes: A double-hit strategy for cancer immunotherapy
por: Brinkhoff, Benjamin, et al.
Publicado: (2014)

A new strategy to target regulatory T cells in solid tumors
por: Thomas-Schoemann, Audrey, et al.
Publicado: (2013)

A novel strategy for modulation of MDSC to enhance cancer immunotherapy
por: Ghansah, Tomar
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_lriiespu3u6mienvj6aibcsjam